Nicolas Collin

1.9k total citations
49 papers, 1.3k citations indexed

About

Nicolas Collin is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Nicolas Collin has authored 49 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 18 papers in Immunology and 14 papers in Infectious Diseases. Recurrent topics in Nicolas Collin's work include Immunotherapy and Immune Responses (11 papers), Influenza Virus Research Studies (8 papers) and vaccines and immunoinformatics approaches (8 papers). Nicolas Collin is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), Influenza Virus Research Studies (8 papers) and vaccines and immunoinformatics approaches (8 papers). Nicolas Collin collaborates with scholars based in Switzerland, United States and United Kingdom. Nicolas Collin's co-authors include Xavier de Radiguès, Christophe Barnier-Quer, Clarissa Teixeira, Jesús G. Valenzuela, Shaden Kamhawi, Régis Gomes, Dia‐Eldin Elnaiem, Livia Brunner, N. Chanter and José M. C. Ribeiro and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and Journal of Controlled Release.

In The Last Decade

Nicolas Collin

48 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicolas Collin Switzerland	21	519	438	433	321	240	49	1.3k
Farnaz Zahedifard Iran	24	945 1.8×	672 1.5×	399 0.9×	136 0.4×	403 1.7×	56	1.5k
Milind M. Gore India	17	668 1.3×	461 1.1×	170 0.4×	707 2.2×	209 0.9×	44	1.3k
Yasaman Taslimi Iran	23	1.1k 2.0×	699 1.6×	308 0.7×	123 0.4×	253 1.1×	50	1.3k
Benjamin Wizel United States	25	549 1.1×	816 1.9×	876 2.0×	496 1.5×	358 1.5×	41	1.8k
Casey Johnson United States	15	590 1.1×	947 2.2×	484 1.1×	747 2.3×	273 1.1×	19	1.8k
Rebecca Sheets United States	19	712 1.4×	360 0.8×	355 0.8×	864 2.7×	507 2.1×	35	1.9k
Brenda L. Fredericksen United States	23	688 1.3×	517 1.2×	751 1.7×	873 2.7×	411 1.7×	31	2.1k
Edward Wright United Kingdom	22	313 0.6×	529 1.2×	297 0.7×	647 2.0×	229 1.0×	70	1.6k
Suh‐Chin Wu Taiwan	25	699 1.3×	579 1.3×	302 0.7×	927 2.9×	570 2.4×	84	1.9k
Henrique Silveira Portugal	20	844 1.6×	551 1.3×	265 0.6×	255 0.8×	247 1.0×	65	1.5k

Countries citing papers authored by Nicolas Collin

Since Specialization

Citations

This map shows the geographic impact of Nicolas Collin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Collin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Collin more than expected).

Fields of papers citing papers by Nicolas Collin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Collin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Collin. The network helps show where Nicolas Collin may publish in the future.

Co-authorship network of co-authors of Nicolas Collin

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Collin. A scholar is included among the top collaborators of Nicolas Collin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Collin. Nicolas Collin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Su, Jinpeng, Livia Brunner, Frank Thiele, et al.. (2023). Activation of CD4 T cells during prime immunization determines the success of a therapeutic hepatitis B vaccine in HBV-carrier mouse models. Journal of Hepatology. 78(4). 717–730. 34 indexed citations

Primard, Charlotte, Élodie Monchâtre-Leroy, Judith del Campo, et al.. (2023). OVX033, a nucleocapsid-based vaccine candidate, provides broad-spectrum protection against SARS-CoV-2 variants in a hamster challenge model. Frontiers in Immunology. 14. 1188605–1188605. 16 indexed citations

Scally, S.W., Giulia Costa, Rajagopal Murugan, et al.. (2023). Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model. npj Vaccines. 8(1). 52–52. 9 indexed citations

Courant, Thomas, et al.. (2023). Meeting vaccine formulation challenges in an emergency setting: Towards the development of accessible vaccines. Pharmacological Research. 189. 106699–106699. 8 indexed citations

Courant, Thomas, et al.. (2022). Designing Adjuvant Formulations to Promote Immunogenicity and Protective Efficacy of Leptospira Immunoglobulin-Like Protein A Subunit Vaccine. Frontiers in Cellular and Infection Microbiology. 12. 918629–918629. 9 indexed citations

Urien, Céline, Joanne McCaffrey, Christophe Barnier-Quer, et al.. (2019). Electroporation of a nanoparticle-associated DNA vaccine induces higher inflammation and immunity compared to its delivery with microneedle patches in pigs. Journal of Controlled Release. 308. 14–28. 37 indexed citations

Auray, Gaël, Obdulio García-Nicolás, Irene Keller, et al.. (2019). Systems Immunology Characterization of Novel Vaccine Formulations for Mycoplasma hyopneumoniae Bacterins. Frontiers in Immunology. 10. 1087–1087. 34 indexed citations

Wang, Chuan, Xiangyang Zhou, Zhiquan Xiang, et al.. (2018). A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis. PLoS neglected tropical diseases. 12(10). e0006870–e0006870. 31 indexed citations

Brunner, Livia, Gaël Auray, Obdulio García-Nicolás, et al.. (2018). System immunology-based identification of blood transcriptional modules correlating to antibody responses in sheep. npj Vaccines. 3(1). 41–41. 14 indexed citations

10.

Younis, Sumera, Christophe Barnier-Quer, Livia Brunner, et al.. (2018). Down selecting adjuvanted vaccine formulations: a comparative method for harmonized evaluation. BMC Immunology. 19(1). 6–6. 8 indexed citations

11.

Varypataki, Eleni Maria, Ana L Silva, Christophe Barnier-Quer, et al.. (2016). Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles. Journal of Controlled Release. 226. 98–106. 79 indexed citations

12.

Ferreira, Viviana P., Michael K. Pangburn, Maha Abdeladhim, et al.. (2016). SALO, a novel classical pathway complement inhibitor from saliva of the sand fly Lutzomyia longipalpis. Scientific Reports. 6(1). 19300–19300. 36 indexed citations

13.

Westdijk, Janny, Mario Barro, Nicolas Collin, et al.. (2013). Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains. Vaccine. 31(9). 1298–1304. 34 indexed citations

14.

McNeela, Edel A., Alison G. Murphy, Joan A. Geoghegan, et al.. (2013). Targeted Nasal Vaccination Provides Antibody-Independent Protection Against Staphylococcus aureus. The Journal of Infectious Diseases. 209(9). 1479–1484. 40 indexed citations

15.

Collin, Nicolas, Teresa C. F. Assumpção, Daniella M. Mizurini, et al.. (2012). Lufaxin, a Novel Factor Xa Inhibitor From the Salivary Gland of the Sand Fly Lutzomyia longipalpis Blocks Protease-Activated Receptor 2 Activation and Inhibits Inflammation and Thrombosis In Vivo. Arteriosclerosis Thrombosis and Vascular Biology. 32(9). 2185–2198. 52 indexed citations

16.

Collin, Nicolas, Régis Gomes, Clarissa Teixeira, et al.. (2009). Sand Fly Salivary Proteins Induce Strong Cellular Immunity in a Natural Reservoir of Visceral Leishmaniasis with Adverse Consequences for Leishmania. PLoS Pathogens. 5(5). e1000441–e1000441. 114 indexed citations

17.

Schwarz, Alexandra, Stefan Helling, Nicolas Collin, et al.. (2009). Immunogenic Salivary Proteins of Triatoma infestans: Development of a Recombinant Antigen for the Detection of Low-Level Infestation of Triatomines. PLoS neglected tropical diseases. 3(10). e532–e532. 27 indexed citations

18.

Collin, Nicolas & Xavier de Radiguès. (2009). Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza. Vaccine. 27(38). 5184–5186. 101 indexed citations

19.

Collin, Nicolas, Jean‐Luc Guérin, Ingo Drexler, et al.. (2005). The poxviral scrapin MV-LAP requires a myxoma viral infection context to efficiently downregulate MHC-I molecules. Virology. 343(2). 171–178. 12 indexed citations

20.

Collin, Nicolas, et al.. (1998). Characterization of the haemolytic activity ofStreptococcus equi. Microbial Pathogenesis. 24(4). 211–221. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact